Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Non Operating Interest Expenses (2011 - 2012)

Updated

Iovance Biotherapeutics' Non Operating Interest Expenses came in at -$5,660 for FY2014, compared with $444,729 in FY2013.

Analysis

Iovance Biotherapeutics (IOVA) Non Operating Interest Expenses (2011 - 2012) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Interest Expenses at $444,729 in FY2013 and $151,507 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 281.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -435.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 126,924.00
Jun 30, 2012 110,810.00
Mar 31, 2012 88,472.00
Dec 31, 2011 119,863.00
Sep 30, 2011 31,644.00
API Access

Iovance Biotherapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY